Literature DB >> 3101840

Increased incidence of true type I diabetes acquired during pregnancy.

K Buschard, I Buch, L Mølsted-Pedersen, P Hougaard, C Kühl.   

Abstract

A longitudinal study was carried out of all patients with newly acquired insulin dependent diabetes during pregnancy (as distinct from non-insulin-dependent gestational diabetes) seen at the Copenhagen Centre for Diabetes and Pregnancy during 1966 to 1980. The series comprised 63 patients with a mean age of 27 (SEM 1) years. At diagnosis the mean fasting blood glucose concentration was 15.6 (1.3) mmol/l and mean maximal insulin dose 49 (3) IU/day. At a prospective follow up examination a mean of 8 (SEM 1) years after diagnosis 46 of 60 patients (77%) were being treated with insulin (35 (2) IU/day) and had a very low mean stimulated plasma C peptide value (0.12 (0.02) nmol/l) suggesting absent or nearly absent beta cell function. The remaining 14 patients (23%), not currently receiving insulin, appeared to be severely glucose intolerant, having a mean fasting blood glucose concentration of 13.4 (1.2) mmol/l. Thus most of these patients developing insulin dependent diabetes during pregnancy had true type I disease. Compared with the age specific incidence of type I diabetes in the background population of women the incidence was at least 70% higher in pregnant than non-pregnant women (p less than 0.001; chi 2 = 11.6; f = 1). This increased incidence occurred in the third trimester when the risk of developing type I diabetes was 3.8 times that of non-pregnant women (p less than 0.000001; chi 2 = 35.6; f = 1). Finally, the risk of developing insulin dependent diabetes during pregnancy was lower when conception occurred in the winter (p less than 0.05; chi 2 = 4.18; f = 1).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3101840      PMCID: PMC1245294          DOI: 10.1136/bmj.294.6567.275

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  17 in total

1.  Systemic lupus erythematosus and pregnancy.

Authors:  M GARSENSTEIN; V E POLLAK; R M KARK
Journal:  N Engl J Med       Date:  1962-07-26       Impact factor: 91.245

2.  Decreased levels of helper T cells: a possible cause of immunodeficiency in pregnancy.

Authors:  V Sridama; F Pacini; S L Yang; A Moawad; M Reilly; L J DeGroot
Journal:  N Engl J Med       Date:  1982-08-05       Impact factor: 91.245

3.  Radioimmunological determination of human C-peptide in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

4.  Incidence of insulin-dependent diabetes mellitus (0--29 years at onset) in Denmark.

Authors:  B Christau; H Kromann; M Christy; O O Andersen; J Nerup
Journal:  Acta Med Scand Suppl       Date:  1979

5.  Plasma glucagon and the insulin:glucagon ratio in gestational diabetes.

Authors:  C Kuhl; J J Holst
Journal:  Diabetes       Date:  1976-01       Impact factor: 9.461

6.  C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.

Authors:  O K Faber; C Binder
Journal:  Diabetes       Date:  1977-07       Impact factor: 9.461

7.  Glucose metabolism during and after pregnancy in normal and gestational diabetic women. 1. Influence of normal pregnancy on serum glucose and insulin concentration during basal fasting conditions and after a challenge with glucose.

Authors:  C Kühl
Journal:  Acta Endocrinol (Copenh)       Date:  1975-08

Review 8.  The thymus-dependent immune system in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus. Animal model and human studies.

Authors:  K Buschard
Journal:  Dan Med Bull       Date:  1985-06

9.  Alterations of peripheral T-lymphocyte subpopulations in patients with insulin-dependent (type 1) diabetes mellitus.

Authors:  K Buschard; C Röpke; S Madsbad; J Mehlsen; T B Sørensen; J Rygaard
Journal:  J Clin Lab Immunol       Date:  1983-03
View more
  9 in total

Review 1.  Screening for diabetes in pregnancy.

Authors:  S Virjee; S Robinson; D G Johnston
Journal:  J R Soc Med       Date:  2001-10       Impact factor: 5.344

Review 2.  Environmental factors in the development of Type 1 diabetes.

Authors:  Hui Peng; William Hagopian
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

3.  Glucose activation of islets of Langerhans up-regulates Toll-like receptor 5: possible mechanism of protection.

Authors:  C Weile; K Josefsen; K Buschard
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

4.  Type 1 (insulin-dependent) diabetes mellitus diagnosed during pregnancy: a clinical and prognostic study.

Authors:  K Buschard; P Hougaard; L Mølsted-Pedersen; C Kühl
Journal:  Diabetologia       Date:  1990-01       Impact factor: 10.122

Review 5.  Prophylactic insulin. Is it 'safe'?

Authors:  K Buschard; T Bock; C Pedersen; I Hageman; K Josefsen
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

6.  Insulin resistance is a risk factor for progression to type 1 diabetes.

Authors:  S Fourlanos; P Narendran; G B Byrnes; P G Colman; L C Harrison
Journal:  Diabetologia       Date:  2004-10-06       Impact factor: 10.122

7.  Expression of the 64 kDa/glutamic acid decarboxylase rat islet cell autoantigen is influenced by the rate of insulin secretion.

Authors:  E Björk; O Kämpe; A Andersson; F A Karlsson
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

8.  Type-specific human papillomavirus detection in cervical smears in Romania.

Authors:  Gabriela Anton; Gheorghe Peltecu; Demetra Socolov; Florinel Cornitescu; Coralia Bleotu; Zorela Sgarbura; Sergiu Teleman; Dominic Iliescu; Anca Botezatu; Cristina D Goia; Irina Huica; Ana-Cristina Anton
Journal:  APMIS       Date:  2010-10-25       Impact factor: 3.205

9.  An Unusual Case of Fulminant Type 1 Diabetes during the Second Trimester of Pregnancy.

Authors:  Tomohiro Okuda; Sadao Yamashita; Yoshio Ogino; Hisashi Kataoka; Jo Kitawaki
Journal:  Case Rep Obstet Gynecol       Date:  2014-08-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.